-
Racial Bias and the Parkinson’s Journey: Reflections from the Staff, Advisors and Community of The Michael J. Fox Foundation
August 2, 2021
… data we have, and the more widely diverse populations we systematically study, the greater our understanding of human … especially women of color — go through in the health care system. I had to fight hard for my voice to be heard in a … but understand the experiences, cultures and belief systems to empower patient dialogue. My favorite Van Gogh …
-
How Strategic De-Risking is Fueling Parkinson’s Treatment Development
April 16, 2026
… in developing an adaptive deep brain stimulation (DBS) system. In DBS, a surgically implanted device sends … helping the brain control movement. Most currently used DBS systems provide a static and unchanging level of stimulation, but Newronika’s system is different. It uses real-time information from the …
-
Proof of Concept of Treatment with Novel Hydroxypyridinone Iron Chelators in a Non-Clinical Model of Parkinson's Disease
… function in response to treatment will be assessed using multiple behavioural tests. Changes in levels of dopamine, …
-
Characterization of LRRK2 Cellular and Signaling Pathways
… for phosphorylation. Through a strong collaboration between multiple investigators with diverse expertise relevant to …
-
IMD-026259 - An Innovative Drug for Disease-Modifying Treatment of Parkinson´s Disease
… target proteins for the MedChem optimized IMD-026259. Multiple in vivo studies (MPTP and 6-OHDA, p.o.) …
-
Investigation of Lipid Metabolism in GBA-associated Parkinsonism
… clumps, a hallmark of Parkinson’s. Cells use multiple mechanisms of ceramide production. Studying …